Key Highlights: Implications: This partnership accelerates peptide therapy access in high-growth markets, challenging incumbents like Sun Pharma in India’s $500M+ peptide segment whi...
Key Highlights: Implications: Jubilant catapults into top-tier CRO/CDMO contender, snatching complex molecule work from Lonza/Capricor as India chemistry talent goes global. Noid...
Key Highlights: Implications: The appointment underlines ChemWerth’s intent to treat India not just as a sourcing base but as a strategic growth market for its re...
Key Highlights: Implications: Lantern’s Bengaluru expansion accelerates U.S. biotech offshoring of AI-drug discovery to India, intensifying talent competition with Dr. Reddy’s and Biocon w...
Relevant Industry Developments India’s biopharmaceutical sector is no longer defined solely by its global dominance in generics. Over the past decade, biologics and biosimilars have emerged as o...
Latest Developments in Pharma Partnerships and Acquisitions India’s pharmaceutical industry has evolved into one of the most dynamic and globally integrated sectors in healthcare. As companies s...
